Annual Net Income
-$259.34 M
-$48.38 M-22.93%
31 March 2024
Summary:
Immunovant annual net profit is currently -$259.34 million, with the most recent change of -$48.38 million (-22.93%) on 31 March 2024. During the last 3 years, it has fallen by -$151.91 million (-141.40%). IMVT annual net income is now -290.64% below its all-time high of -$66.39 million, reached on 31 March 2020.IMVT Net Income Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Net Income
-$109.12 M
-$21.97 M-25.21%
30 September 2024
Summary:
Immunovant quarterly net profit is currently -$109.12 million, with the most recent change of -$21.97 million (-25.21%) on 30 September 2024. Over the past year, it has dropped by -$50.46 million (-86.01%). IMVT quarterly net income is now -59825.78% below its all-time high of $182.70 thousand, reached on 30 June 2019.IMVT Quarterly Net Income Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM Net Income
-$323.01 M
-$50.46 M-18.51%
30 September 2024
Summary:
Immunovant TTM net profit is currently -$323.01 million, with the most recent change of -$50.46 million (-18.51%) on 30 September 2024. Over the past year, it has dropped by -$67.75 million (-26.54%). IMVT TTM net income is now -105176.77% below its all-time high of $307.40 thousand, reached on 30 September 2019.IMVT TTM Net Income Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
IMVT Net Income Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -22.9% | -86.0% | -26.5% |
| 3 y3 years | -141.4% | -189.4% | -152.1% |
| 5 y5 years | - | -10000.0% | -10000.0% |
IMVT Net Income High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -141.4% | at low | -189.4% | at low | -152.1% | at low |
| 5 y | 5 years | -290.6% | at low | <-9999.0% | at low | <-9999.0% | at low |
| alltime | all time | -290.6% | at low | <-9999.0% | at low | <-9999.0% | at low |
Immunovant Net Income History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | -$109.12 M(+25.2%) | -$323.01 M(+18.5%) |
| June 2024 | - | -$87.15 M(+15.7%) | -$272.55 M(+5.1%) |
| Mar 2024 | -$259.34 M(+22.9%) | -$75.32 M(+46.5%) | -$259.34 M(+6.5%) |
| Dec 2023 | - | -$51.42 M(-12.3%) | -$243.45 M(-4.6%) |
| Sept 2023 | - | -$58.66 M(-20.7%) | -$255.26 M(+4.4%) |
| June 2023 | - | -$73.94 M(+24.4%) | -$244.52 M(+15.9%) |
| Mar 2023 | -$210.96 M(+34.6%) | -$59.43 M(-6.0%) | -$210.96 M(+6.2%) |
| Dec 2022 | - | -$63.23 M(+31.9%) | -$198.70 M(+12.4%) |
| Sept 2022 | - | -$47.93 M(+18.7%) | -$176.86 M(+6.1%) |
| June 2022 | - | -$40.37 M(-14.4%) | -$166.63 M(+6.3%) |
| Mar 2022 | -$156.73 M | -$47.17 M(+14.0%) | -$156.73 M(+13.8%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2021 | - | -$41.38 M(+9.8%) | -$137.72 M(+7.5%) |
| Sept 2021 | - | -$37.70 M(+23.7%) | -$128.11 M(+15.2%) |
| June 2021 | - | -$30.47 M(+8.2%) | -$111.19 M(+3.5%) |
| Mar 2021 | -$107.43 M(+61.8%) | -$28.16 M(-11.4%) | -$107.43 M(+7.6%) |
| Dec 2020 | - | -$31.78 M(+52.9%) | -$99.82 M(+25.8%) |
| Sept 2020 | - | -$20.79 M(-22.2%) | -$79.34 M(+35.8%) |
| June 2020 | - | -$26.71 M(+30.0%) | -$58.43 M(+85.3%) |
| Mar 2020 | -$66.39 M | -$20.55 M(+81.9%) | -$31.54 M(+187.0%) |
| Dec 2019 | - | -$11.30 M(-9129.6%) | -$10.99 M(-3674.7%) |
| Sept 2019 | - | $125.10 K(-31.5%) | $307.40 K(+68.6%) |
| June 2019 | - | $182.70 K(<-9900.0%) | $182.30 K(<-9900.0%) |
| Mar 2019 | - | -$400.00 | -$400.00 |
FAQ
- What is Immunovant annual net profit?
- What is the all time high annual net income for Immunovant?
- What is Immunovant annual net income year-on-year change?
- What is Immunovant quarterly net profit?
- What is the all time high quarterly net income for Immunovant?
- What is Immunovant quarterly net income year-on-year change?
- What is Immunovant TTM net profit?
- What is the all time high TTM net income for Immunovant?
- What is Immunovant TTM net income year-on-year change?
What is Immunovant annual net profit?
The current annual net income of IMVT is -$259.34 M
What is the all time high annual net income for Immunovant?
Immunovant all-time high annual net profit is -$66.39 M
What is Immunovant annual net income year-on-year change?
Over the past year, IMVT annual net profit has changed by -$48.38 M (-22.93%)
What is Immunovant quarterly net profit?
The current quarterly net income of IMVT is -$109.12 M
What is the all time high quarterly net income for Immunovant?
Immunovant all-time high quarterly net profit is $182.70 K
What is Immunovant quarterly net income year-on-year change?
Over the past year, IMVT quarterly net profit has changed by -$50.46 M (-86.01%)
What is Immunovant TTM net profit?
The current TTM net income of IMVT is -$323.01 M
What is the all time high TTM net income for Immunovant?
Immunovant all-time high TTM net profit is $307.40 K
What is Immunovant TTM net income year-on-year change?
Over the past year, IMVT TTM net profit has changed by -$67.75 M (-26.54%)